Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study

article

Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/03009742.2010.523012
P698PubMed publication ID21077801

P50authorKerstin BrismarQ37376842
P2093author name stringI Hafström
B Tengstrand
I-L Engvall
P2860cites workSafety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.Q31000488
Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?Q33301155
Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritisQ33565442
Insulin-like growth factors (IGFs) and IGF-binding proteins in nephrotic syndrome children on glucocorticoidQ35193760
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990sQ35554980
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3.Q35636905
Perspectives on glucocorticoid-induced osteoporosisQ35721823
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions.Q35855164
Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patientsQ36356750
Glucocorticoid-induced osteoporosis: an updateQ36470205
Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized studyQ37129537
Association of body fat with C-reactive protein in rheumatoid arthritis.Q37163594
Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional studyQ37206912
Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritisQ39908195
Bone mass measurement and bone metabolism in rheumatoid arthritis: a reviewQ40945707
Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritisQ42498499
Relationship between obesity, insulin resistance, and coronary heart disease riskQ44133524
Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial.Q44912980
Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influencesQ44927103
Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synoviumQ46335270
Early rheumatoid arthritis and body compositionQ46344030
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trialQ46778815
Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral densityQ46929682
Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.Q52209760
Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.Q54372396
Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.Q54524505
Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin‐like growth factorQ58329736
P433issue3
P921main subjectrheumatoid arthritisQ187255
P304page(s)161-168
P577publication date2010-11-16
P1433published inScandinavian Journal of RheumatologyQ15767622
P1476titleTreatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study
P478volume40

Reverse relations

cites work (P2860)
Q90354326A Swedish register-based, long-term inception cohort study of patients with rheumatoid arthritis - results of clinical relevance
Q35691844A long-term, observational cohort study on the safety of low-dose glucocorticoids in ankylosing spondylitis: adverse events and effects on bone mineral density, blood lipid and glucose levels and body mass index
Q36154527Body composition in patients with rheumatoid arthritis is not different than healthy subjects
Q35834171Dual X-Ray Absorptiometry Whole Body Composition of Bone Tissue in Rheumatoid Arthritis - a Cross-Sectional Study
Q41016595Dual X-ray Absorptiometry Whole Body Composition of Adipose Tissue in Rheumatoid Arthritis
Q55092131Effect of long-term low dose prednisolone administration on bone mineral density: Relating to non-compliant women with rheumatoid arthritis.
Q55176337Lean Mass and Disease Activity are the Best Predictors of Bone Mineral Loss in the Premenopausal Women with Rheumatoid Arthritis.
Q36464831Muscle density in rheumatoid arthritis: associations with disease features and functional outcomes
Q36079448Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study

Search more.